decisionhealth Newsletters, Answer Books - 2006 Issue 3 (March)
Program_Memos / 2000 / AB-00-76
Subscribe or sign in to view the full article.
Article Overview
This article summarizes a Medicare program memorandum from HCFA/DHHS that updates policy handling for erythropoietin in the dialysis setting. It is relevant to Medicare billing, coverage policy, and program integrity staff who need to understand the scope of the memorandum, the timing of implementation, and the general framework for review activities and local policy discretion.
Why This Topic Matters
The memorandum affects how certain Medicare claims are handled and how reviewers focus their oversight, making it important for organizations involved in dialysis-related billing and compliance. It also clarifies implementation timing and indicates where local policy discretion may apply.
Article Sections
-
Transmittal AB-00-76
Identifies the memorandum transmittal, issuing organizations, date, and subject matter. It establishes the administrative context for the policy update.
What You Will Learn
- The general scope of the Medicare policy update described in the memorandum.
- How the article frames review activity and oversight for the affected claims.
- Which organizations issued the memorandum and the timeframe for implementation.
- Where the memorandum indicates that local policy discretion may apply.
Who Should Read This
- Medicare billers and coders
- Hospital and dialysis facility compliance staff
- Carrier and intermediary policy staff
- Program integrity reviewers
- Healthcare reimbursement analysts
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com